The influence of biologics on the microbiome in immune-mediated inflammatory diseases: A systematic review
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The influence of biologics on the microbiome in immune-mediated inflammatory diseases: A systematic review
Authors
Keywords
Infliximab, Microbiome, Pharmacomicrobiomics
Journal
BIOMEDICINE & PHARMACOTHERAPY
Volume 141, Issue -, Pages 111904
Publisher
Elsevier BV
Online
2021-07-14
DOI
10.1016/j.biopha.2021.111904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gut–Skin Axis: Current Knowledge of the Interrelationship between Microbial Dysbiosis and Skin Conditions
- (2021) Britta De Pessemier et al. Microorganisms
- Changes in the Intestinal Microbiota Are Seen Following Treatment with Infliximab in Children with Crohn’s Disease
- (2020) Kinga Kowalska-Duplaga et al. Journal of Clinical Medicine
- Host–microbiota interactions in immune-mediated diseases
- (2020) William E. Ruff et al. NATURE REVIEWS MICROBIOLOGY
- The Interplay between Mucosal Microbiota Composition and Host Gene-Expression is Linked with Infliximab Response in Inflammatory Bowel Diseases
- (2020) Nikolas Dovrolis et al. Microorganisms
- Changes in the Intestinal Microbiota of Patients with Inflammatory Bowel Disease with Clinical Remission during an 8-Week Infliximab Infusion Cycle
- (2020) Gyeol Seong et al. Microorganisms
- Quantitative changes in selected bacteria in the stool during the treatment of Crohn's disease
- (2020) Dominika Salamon et al. Advances in Medical Sciences
- Impact of Preservation Method and 16S rRNA Hypervariable Region on Gut Microbiota Profiling
- (2019) Zigui Chen et al. mSystems
- A simple translation from indices of species diversity to indices of phylogenetic diversity
- (2019) Sandrine Pavoine et al. ECOLOGICAL INDICATORS
- Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients with Inflammatory Bowel Diseases
- (2019) Konrad Aden et al. GASTROENTEROLOGY
- IL-4Rα Blockade by Dupilumab Decreases Staphylococcus aureus Colonization and Increases Microbial Diversity in Atopic Dermatitis
- (2019) Chris Callewaert et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Gut Microbiome in Psoriasis is Perturbed Differently During Secukinumab and Ustekinumab Therapy and Associated with Response to Treatment
- (2019) Nai-Lun Yeh et al. CLINICAL DRUG INVESTIGATION
- IL‐17 Inhibition in Spondyloarthritis Associates with Subclinical Gut Microbiome Perturbations and a Distinctive IL‐25‐Driven Intestinal Inflammation
- (2019) Julia Manasson et al. Arthritis & Rheumatology
- 399 Blockade of the IL-12/IL-23 pathway with ustekinumab modulates the composition of the microbiome in lesional skin from psoriasis patients
- (2018) A. Tsianakas et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Longitudinal Study of the Psoriasis-Associated Skin Microbiome during Therapy with Ustekinumab in a Randomized Phase 3b Clinical Trial
- (2018) Michael A. Loesche et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Fecal Microbiota Signatures Are Associated with Response to Ustekinumab Therapy among Crohn’s Disease Patients
- (2018) Matthew K. Doherty et al. mBio
- Microbiota Composition May Predict Anti-Tnf Alpha Response in Spondyloarthritis Patients: an Exploratory Study
- (2018) Thomas Bazin et al. Scientific Reports
- Gut Microbiota Offers Universal Biomarkers across Ethnicity in Inflammatory Bowel Disease Diagnosis and Infliximab Response Prediction
- (2018) Youlian Zhou et al. mSystems
- Introduction, comparison, and validation of Meta-Essentials : A free and simple tool for meta-analysis
- (2017) Robert Suurmond et al. Research Synthesis Methods
- Anti-TNF Therapy Response in Patients with Ulcerative Colitis Is Associated with Colonic Antimicrobial Peptide Expression and Microbiota Composition
- (2016) Maria K. Magnusson et al. Journal of Crohns & Colitis
- Fecal Microbiota in Pediatric Inflammatory Bowel Disease and Its Relation to Inflammation
- (2015) Kaija-Leena Kolho et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- Inflammation, Antibiotics, and Diet as Environmental Stressors of the Gut Microbiome in Pediatric Crohn’s Disease
- (2015) James D. Lewis et al. Cell Host & Microbe
- Tu1302 Anti-TNF-α Induction Regimen Modulates Gut Microbiota Molecular Composition While Inducing Clinical Response in Crohn's Disease Patients: Toward a Personalized Medicine
- (2015) Franco Scaldaferri et al. GASTROENTEROLOGY
- Anti-tumour Necrosis Factor Treatment with Adalimumab Induces Changes in the Microbiota of Crohn’s Disease
- (2015) David Busquets et al. Journal of Crohns & Colitis
- P-214 Gut Microbial Response to Anti-Tnf Therapy in IBD
- (2014) Chen Lea Ann et al. INFLAMMATORY BOWEL DISEASES
- Mucosa-associated Faecalibacterium prausnitzii and Escherichia coli co-abundance can distinguish Irritable Bowel Syndrome and Inflammatory Bowel Disease phenotypes
- (2014) Mireia Lopez-Siles et al. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started